Pharmacologic treatments for covid-19 patients

Itolizumab vs Standard care


Hospitalized patients

Forest plots
(last update: 2021-04-08)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=167

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
CTRI/2020/05/024959
Kumar S, Exp Opin Biol Ther, 2021
Full text
Commentary
Commentary
Private

Itolizumab

Standard care

RCT Patients with confirmed COVID-19 (severe) admitted to 4 centers in India N=32
Some concerns
Details

Full description